Trial · NCT00409773
Registered outcomes15
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 15 of 15
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Percent Change From Baseline in Low Density Lipoprotein (LDL-C) at Week 6 | Baseline and 6 Weeks | |
| Secondary | Percent Change From Baseline in Total Cholesterol(mg/dL) at Week 6 | Baseline and 6 Weeks | |
| Secondary | Percent Change From Baseline in Triglyceride (TG) (mg/dL) at Week 6 | Baseline and 6 Weeks | |
| Secondary | Percent Change From Baseline in High Density Lipoprotein Cholesterol (HDL-C) at Week 6 | Baseline and 6 Weeks | |
| Secondary | Percent Change From Baseline in Non- High Density Lipoprotein Cholesterol (Non-HDL-C) at Week 6 | Baseline and 6 Weeks | |
| Secondary | Percent Change From Baseline in Very Low Density Lipoprotein Cholesterol (VLDL-C) at Week 6 | Baseline and 6 Weeks | |
| Secondary | Percent Change From Baseline in Apolipoprotein- B (Apo-B) at Week 6 | Baseline and 6 Weeks | |
| Secondary | Percent Change From Baseline in Apolipoprotein-A1 (Apo-A1) at Week 6 | Baseline and 6 Weeks | |
| Secondary | Percent Change From Baseline in Total-Cholesterol: High Density Lipoprotein-Cholesterol (Total-C:HDL- C) at Week 6 | Baseline and 6 Weeks | |
| Secondary | Percent Change From Baseline in Low Density Lipoprotein Cholesterol: High Density Lipoprotein Cholesterol (LDL-C: HDL-C) at Week 6 | Baseline and 6 Weeks | |
| Secondary | Percent Change From Baseline in Apolipoprotein-B: Apolipoprotein-A1 (Apo-B:Apo-A1) at Week 6 | Baseline and 6 weeks | |
| Secondary | Percent Change From Baseline in Non-High Density Lipoprotein Cholesterol: High Density Lipoprotein Cholesterol (Non-HDL-C:HDL-C) at Week 6 | Baseline and 6 Weeks | |
| Secondary | Percent Change From Baseline in Low Density Lipoprotein Cholesterol (LDL-C) at Week 6 in Patients With Atherosclerotic Vascular Disease (AVD) | Baseline and 6 Weeks | |
| Secondary | Percent Change From Baseline in Low Density Lipoprotein Cholesterol (LDL-C) at Week 6 in Patients Without Atherosclerotic Vascular Disease (AVD) | Baseline and 6 Weeks | |
| Secondary | Percent Change From Baseline in High-Sensitivity C-reactive (Hs-CRP) (mg/dL) at Week 6 | Baseline and 6 Weeks |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00409773/registered